About Us
Conditons & Procedures
Conditions
Procedures
Faculty
Patient Center
Education & Training
Research
News
Message from the Chief
Professor & Chief,
Division of Adult Cardiothoracic Surgery
Georg M. Wieselthaler, M.D., New Director & Surgical Chief, Cardiac Transplantation
Dr. Wieselthaler is one of the world's foremost experts in mechanical circulatory support for end-stage heart failure patients and a medical innovator in ventricular assist device (VAD) systems.
Make a Gift
A gift to the Adult Cardiac Surgery helps us discover
new
treatments and cures.
Arthur Hill, M.D.
Professor of Surgery
Division of Adult Cardiothoracic Surgery
Contact Information
San Francisco, CA 94143-0807
(415) 206-8673 Appointments
(415) 206-4622 Office
(415) 206-5484 Fax
ahill@sfghsurg.ucsf.edu
BiographyEducation
- Tufts University School of Medicine, M.D., 1982
Residencies
- University of California, Los Angeles, Intern Surgery, 1982-1983
- University of California, Los Angeles, Resident General Surgery, 1983-1988
- Stanford University Medical Center, Chief Resident Non-Cardiac Thoracic Surgery, 1991
- The Cleveland Clinic Foundation Cardiothoracic Surgery, Associate Staff, 1991-1992
Fellowships
- Cardiovascular Research Institute, University of California, San Francisco, Postdoctoral Fellow Cardiovascular Research, 1984-1986
- Stanford University Medical Center, Resident, Cardiovascular Surgery, 1988-1990
- Stanford University Medical Center, Fellow, Cardiopulmonary Transplantation, 1990
Board Certification
- American Board of Surgery
- American Board of Surgery, Subspecialty Surgical Critical Care
- American Board of Thoracic Surgery
Research Interests
- Anastomotic technology for use in minimally invasive and robotic CABG
- Medical uses of Nitinol
- Nitinol for aortic, mitral and tricuspid repair and replacement
- PLAATO Left Atrial Appendage Occlusion Device for Treatment of Atrial Fibrillation
- Sealant, Super-sealant, and hemostatic devices used in Surgery
- Vascular peptide coating to promote endothelial adhesion and proliferation
Pre-clinical and clinical development of new medical technology including:
Biography
Dr. Arthur Hill is Professor of Clinical Surgery and Chief of Thoracic Surgery at San Francisco General Hospital. Dr. Hill has been on the faculty since 2000. Dr. Hill is a graduate of Tufts University School of Medicine. He completed his General Surgery Residency at the UCLA School of Medicine and his training in Cardiovascular Surgery, Cardiothoracic Surgery and Cardiopulmonary Transplantation at Stanford University. Dr. Hill's area of clinical expertise is in Cardiothoracic Surgery.
Dr. Hill is certified by the American Board of Surgery, the American Board of Thoracic Surgery, and the American Board of Surgical Critical Care. His clinical interest include general thoracic, cardiac and thoracic trauma surgery. Dr. Hill is a fellow of the American College of Cardiology, American College of Surgeons, American College of Chest Physicians, and a member of the International Society for Heart and Lung Transplantation, American Heart Association, California Medical Association, and the American Medical Association.
Selected Publications
- Hill AC, Maroney TP, Virmani R. Facilitated coronary anastomosis using a nitinol U-Clip device: bovine model. J Thorac Cardiovasc Surg. 121: 859-70, May/2001. This is a pre-clinical study of the efficacy of the Nitinol U-clip for coronary anastomosis in calves, and was compared to sutured coronary anastomosis. A. Hill designed the study, performed coronary and jugular anastomoses in all animals, presented the paper at the American Association of Thoracic Surgeons meeting, and wrote the paper.
- Wolf RK, Alderman EL, Caskey MP, Raczkowski AR, Dullum MK, Lundell DC, Hill AC, Wang N, Daniel MA. Clinical and six-month angiographic evaluation of coronary arterial graft interrupted anastomoses by use of a self-closing clip device: a multicenter prospective clinical trial. J Thorac Cardiovasc Surg. 26: 168-77; discussion 177-8, Jul/2003. This is the clinical study that evolved from the pre-clinical studies that were performed in calves. A. Hill designed the clinical study and was Principal Investigator. (First authorship was awarded to the investigators with the highest volume of cases). This device was FDA approved and is currently marketed by Medtronic Inc. A. Hill is named in patents related to this device.
- Fjellbirkeland L, Canbier S, Hill AC, Broaddus VC, Brunetta P, ten Dijke P, Dolganov G, Jablons D, Nishimura SL. Integrin-mediated Activation of TGF-ß Inhibits Human Airway Proliferation in situ. Am J Path. 533-42, 08/2003. A. Hill participated in specimen collection, data analysis, and co-wrote the paper.
- Li C, Hill AC, Imran I. Peptide-coated Vascular Grafts: An in vivo Study in Sheep. Hemodialysis International. 365-372, 2004. This is a sheep study comparing peptide coated vascular prosthesis versus uncoated vascular prosthetic material and simulating dialysis access grafts. A. Hill designed the animal study, performed the surgical procedures in all of the sheep, performed data collection and analysis, and co-wrote the paper.
- Li, C, Hill AC, Imran M. In vitro and in vivo studies of ePTFE vascular grafts treated with P15 peptide. Journal of Biomaterials Science. Polymer Edition Ed vol. 16: 875-891(17), 07/2005. This study compared the data obtained from in vitro analysis of peptide coated prosthetic grafts to in vivo studies of peptide coated vascular grafts. A. Hill designed the in vivo studies and performed the graft implants. A. Hill performed in vivo data analysis and co-wrote the paper. C. Li is a polymer biochemist who developed the preparation and methodology for P15 peptide coating.
